The selloff in Eli Lilly's shares was “overdone,” according to RBC Capital Markets, which noted that the overall safety ...

The Food and Drug Administration has recorded two ‘serious’ cases in patients taking Eli Lilly’s weight-loss pill.

Eli Lilly stock dips after FAERS reports liver failure tied to obesity drug Foundayo (orforglipron). Read more here.

As Eli Lilly gets off to the races with the launch of its flagship oral GLP-1 Foundayo, the Indianapolis drugmaker—and at ...

With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

If you are trying to lose weight, you may be considering a prescription treatment option alongside changes in daily routines. One medicine you might hear about is Foundayo (orforglipron). The FDA ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Foundayo is used for weight loss in adults with obesity or who are overweight with a weight-related condition. It is available as an oral tablet taken once per day. Foundayo can be taken with or ...

Share on Pinterest The FDA has approved a new once-daily GLP-1 pill for weight loss. Image Credit: Healthline/Photo by Eli Lilly Federal regulators have approved the GLP-1 tablet Foundayo for use in ...